4 Recruiting Progressive Multiple Sclerosis Phase 1 Clinical Trials
Active phase 1 studies for progressive multiple sclerosis enrolling across the USA. Verify eligibility and contact site coordinators.
All Progressive Multiple Sclerosis studiesPhase 1 Studies for Progressive Multiple Sclerosis
🟢 Recruiting Phase1 / Phase2
Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Kinetics Following YTB323 Administration in Participants With Non-active Progressive Multiple Sclerosis (PMS)
📍 Novartis Investigative Site — Darlinghurst, New South Wales
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1
A Study of KYV-101, a CD19 CAR T Cell Therapy, in Participants With Treatment Refractory Progressive Multiple Sclerosis
📍 University of California, San Francisco, Multiple Sclerosis Center — San Francisco, California
View Study & Checklist ➔ 🟢 Recruiting Phase1
Obe-cel in Refractory Progressive Forms of Multiple Sclerosis
📍 Stanford University — Redwood City, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1
ABA-101 in Participants With Progressive Multiple Sclerosis
📍 Johns Hopkins University — Baltimore, Maryland
View Study & Checklist ➔